| 1 |
30937691 | Correction to: A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-XL. | 2019 Aug |
1 |
| 2 |
30250075 | Sensitizing non-small cell lung cancer to BCL-xL-targeted apoptosis. | 2018 Sep 24 |
1 |
| 3 |
28032735 | Combined Treatment with Stattic and Docetaxel Alters the Bax/Bcl-2 Gene Expression Ratio in Human Prostate Cancer Cells | 2016 Nov 1 |
1 |
| 4 |
24058878 | ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells. | 2013 |
1 |
| 5 |
21773733 | A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-XL. | 2012 Aug |
1 |
| 6 |
22490358 | [The effect of cell killing by ABT-737 synergized with docetaxel in human prostate cancer PC-3 cells]. | 2012 Feb 1 |
1 |
| 7 |
21914853 | The Bcl-2/Bcl-X(L)/Bcl-w inhibitor, navitoclax, enhances the activity of chemotherapeutic agents in vitro and in vivo. | 2011 Dec |
1 |
| 8 |
21159614 | Contrasting effects of nutlin-3 on TRAIL- and docetaxel-induced apoptosis due to upregulation of TRAIL-R2 and Mcl-1 in human melanoma cells. | 2010 Dec |
2 |
| 9 |
18691406 | Zoledronic acid increases docetaxel cytotoxicity through pMEK and Mcl-1 inhibition in a hormone-sensitive prostate carcinoma cell line. | 2008 Aug 8 |
2 |
| 10 |
18789152 | Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-1 and LTbeta-R in hormone- and drug resistant prostate cancer cell line, DU-145. | 2008 Sep 12 |
1 |
| 11 |
16969094 | Mcl-1 is a relevant molecular target for antisense oligonucleotide strategies in gastric cancer cells. | 2006 Oct |
1 |